首页> 外文OA文献 >Corrigendum to “RVX-208, a BET-inhibitor for treating atherosclerotic cardiovascular disease, raises ApoA-I/HDL and represses pathways that contribute to cardiovascular disease” Atherosclerosis 247 (2016) 48–57

【2h】

Corrigendum to “RVX-208, a BET-inhibitor for treating atherosclerotic cardiovascular disease, raises ApoA-I/HDL and represses pathways that contribute to cardiovascular disease” Atherosclerosis 247 (2016) 48–57

机译：“用于治疗动脉粥样硬化性心血管疾病的BET抑制剂RVX-208，提高ApoA-I / HDL并抑制促成心血管疾病的途径”的勘误动脉粥样硬化247（2016）48-57

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Gilham Dean; Wasiak Sylwia; Tsujikawa Laura M.; Halliday Christopher; Norek Karen; Patel Reena G.; Kulikowski Ewelina; Johansson Jan; Sweeney Michael; Wong Norman C.W.;
展开▼
作者单位

展开▼
年度 2016
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. The role of niacin in raising high-density lipoprotein cholesterol to reduce cardiovascular events in patients with atherosclerotic cardiovascular disease and optimally treated low-density lipoprotein cholesterol Rationale and study design. The Atherothrombosis Intervention in Metabolic syndrome with low HDL/high triglycerides: Impact on Global Health outcomes (AIM-HIGH). [J] . Anonymous The American heart journal . 2011,第3期

机译：烟酸在提高高密度脂蛋白胆固醇，减少动脉粥样硬化性心血管疾病和最佳治疗低密度脂蛋白胆固醇患者的心血管事件中的作用原理和研究设计。低HDL /高甘油三酸酯对代谢综合征的动脉粥样硬化干预：对全球健康结果的影响（AIM-HIGH）。
2. The role of niacin in raising high-density lipoprotein cholesterol to reduce cardiovascular events in patients with atherosclerotic cardiovascular disease and optimally treated low-density lipoprotein cholesterol: baseline characteristics of study participants. The Atherothrombosis Intervention in Metabolic syndrome with low HDL/high triglycerides: impact on Global Health outcomes (AIM-HIGH) trial. [J] . Anonymous The American heart journal . 2011,第3期

机译：烟酸在提高高密度脂蛋白胆固醇，减少动脉粥样硬化性心血管疾病和最佳治疗的低密度脂蛋白胆固醇患者心血管事件中的作用：研究参与者的基线特征。低HDL /高甘油三酸酯对代谢综合征的动脉粥样硬化干预：对全球健康结果（AIM-HIGH）试验的影响。
3. Lp(a) (Lipoprotein(a)) Levels Predict Progression of Carotid Atherosclerosis in Subjects With Atherosclerotic Cardiovascular Disease on Intensive Lipid Therapy: An Analysis of the AIM-HIGH (Atherothrombosis Intervention in Metabolic Syndrome With Low HDL/High Triglycerides: Impact on Global Health Outcomes) Carotid Magnetic Resonance Imaging SubstudyBrief Report [J] . Hippe Daniel S., Phan Binh An P., Sun Jie, Arteriosclerosis, thrombosis, and vascular biology . 2018,第3期

机译：LP（a）（脂蛋白（a））水平预测患有动脉粥样硬化心血管疾病的颈动脉动脉粥样硬化的水平，对血液疗法的动脉粥样硬化疾病：对低HDL /高甘油三酯中代谢综合征的目标高（动脉癌干预措施：对全球影响的影响健康结果）颈动脉磁共振成像摘废上网报告
4. Low HDL-C predicts Subclinical Atherosclerosis in Asymptomatic South East Asian Patients without known Cardiovascular Disease [C] . Lee R., Ng K., Hsu L.F., International Congress on Coronary Artery Disease . 2009

机译：低HDL-C预测无症状东南亚患者的亚临床动脉粥样硬化，没有已知心血管疾病
5. The role of niacin in raising high-density lipoprotein cholesterol to reduce cardiovascular events in patients with atherosclerotic cardiovascular disease and optimally treated low-density lipoprotein cholesterol: Baseline characteristics of study participants. The Atherothrombosis Intervention in Metabolic syndrome with low HDL/high triglycerides: Impact on Global Health outcomes (AIM-HIGH) trial [O] . -1

机译：烟酸在提高高密度脂蛋白胆固醇患者减少动脉粥样硬化心血管疾病的心血管事件中的作用和最佳治疗低密度脂蛋白胆固醇：研究参与者的基线特征。该动脉粥样硬化干预代谢综合征与低HDL /高甘油三酯：影响全球健康结果（aIm-HIGH）试验
6. RVX-208, a BET-inhibitor for treating atherosclerotic cardiovascular disease, raises ApoA-I/HDL and represses pathways that contribute to cardiovascular disease [O] . Gilham Dean, Wasiak Sylwia, Tsujikawa Laura M., 2016

机译：用于治疗动脉粥样硬化性心血管疾病的BET抑制剂RVX-208升高ApoA-I / HDL并抑制导致心血管疾病的途径

代理获取

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号